nDatalyze Corp (TSE:NDAT) has released an update.
nDatalyze Corp. has provided an update on its clinical study, highlighting the importance of understanding the genetic and environmental interplay in mental health issues to enhance treatment efficacy. In addition, the company’s Mindbalanced operations have adopted a franchise-style model, integrating DNA data and TMS treatments to personalize mental health care.
For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.
